Valproic Acid in Parkinson's Disease: A Friend or Foe?
DOI:
https://doi.org/10.14738/bjhr.1203.18873Abstract
There have been several reports of Parkinson's disease like symptoms being a side effect of Valproic Acid use. Valproic Acid is a drug prescribed for Epileptic seizures and also as a mood stabilizer. Despite the said reports of Parkinson's like side effects, several other studies had shown it to in fact be neuroprotective and perhaps therapeutic against PD in vivo. This review will center around these few studies, bring their results and ask for more experimentation to solve this issue of whether Valproic Acid triggers Parkinson's or perhaps triggers a healing from it. I would hypothesize in this essay that perhaps the supposed PD-like symptoms from VA use are on the other side of the spectrum, for example that PD tremor is being countered by Valproic Acid stiffness which puts an emphasis on its ideal dosage.
References
Muralidharan A, Rahman J, Banerjee D, et al. (June 23, 2020) Parkinsonism: A Rare Adverse Effect of Valproic Acid. Cureus 12(6): e8782. doi:10.7759/cureus.8782 https://www.cureus.com/articles/33023-parkinsonism-a-rare-adverse-effect-of-valproic-acid#!/
Kazumasa Sekiguchi. Toshihiro Mashiko. Reiji Koide. Kensuke Kawai, Shigeru Fujimot, Ryota Tanaka. A Case of Long-Term Exposure to Valproic Acid Mimicking Tremor-Dominant Parkinson’s Disease. Case Reports. Year: 2023. Volume 13. Page/Article: 17. DOI: 10.5334/tohm.755 https://tremorjournal.org/articles/10.5334/tohm.755#ethics-and-consent
Zhang C, Yuan X, Hu Z, Liu S, Li H, Wu M, Yuan J, Zhao Z, Su J, Wang X, Liao Y, Liu Q. Valproic Acid Protects Primary Dopamine Neurons from MPP+-Induced Neurotoxicity: Involvement of GSK3β Phosphorylation by Akt and ERK through the Mitochondrial Intrinsic Apoptotic Pathway. Biomed Res Int. 2017; 2017:8124501. doi: 10.1155/2017/8124501. Epub 2017 Mar 22. PMID: 28421199; PMCID: PMC5380829. https://pmc.ncbi.nlm.nih.gov/articles/PMC5380829/
Ximenes JC, Neves KR, Leal LK, do Carmo MR, Brito GA, Naffah-Mazzacoratti Mda G, Cavalheiro ÉA, Viana GS. Valproic Acid Neuroprotection in the 6-OHDA Model of Parkinson's Disease Is Possibly Related to Its Anti-Inflammatory and HDAC Inhibitory Properties. J Neurodegener Dis. 2015; 2015:313702. doi: 10.1155/2015/313702. Epub 2015 Feb 19. PMID: 26317011; PMCID: PMC4437346. https://pmc.ncbi.nlm.nih.gov/articles/PMC4437346/
Ching-Long Lai, Chun-Chung Lu, Hui-Ching Lin, Yueh-Feng Sung, Yi-Pin Wu, Jau-Shyong Hong, Giia-Sheun Peng, Valproate is protective against 6-OHDA-induced dopaminergic neurodegeneration in rodent midbrain: A potential role of BDNF up-regulation. Journal of the Formosan Medical Association, Volume 118, Issue 1, Part 3, 2019, Pages 420-428, ISSN 0929-6646, https://doi.org/10.1016/j.jfma.2018.06.017. (https://www.sciencedirect.com/science/article/pii/S0929664617306794)
Harrison, I.F., Crum, W.R., Vernon, A.C. and Dexter, D.T. (2015), Valproate neurorestoration in Parkinsonian rats. Br J Pharmacol, 172: 4200-4215. https://doi.org/10.1111/bph.13208https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bph.13208
Kim T, Song S, Park Y, Kang S, Seo H. HDAC Inhibition by Valproic Acid Induces Neuroprotection and Improvement of PD-like Behaviors in LRRK2 R1441G Transgenic Mice. Exp Neurobiol 2019; 28:504-515. https://doi.org/10.5607/en.2019.28.4.504https://www.en-journal.org/journal/view.html?uid=467
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Amos Gelbard
This work is licensed under a Creative Commons Attribution 4.0 International License.
